| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OpGen Inc (F: 6502)
6502 Technical Analysis
5
| As on 3rd Jan 2023 6502 STOCK Price closed @ 0.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.26 & Strong Sell for SHORT-TERM with Stoploss of 2.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
6502STOCK Price
| Open | 0.11 | Change | Price | % |
| High | 0.13 | 1 Day | 0.02 | 20.00 |
| Low | 0.11 | 1 Week | 0.02 | 20.00 |
| Close | 0.12 | 1 Month | -0.08 | -40.00 |
| Volume | N/A | 1 Year | -1.69 | -93.37 |
| 52 Week High 3.08 | 52 Week Low 0.09 | ||||
F Germany Most Active Stocks
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 6502 Daily Charts |
6502 Intraday Charts |
Whats New @ Bazaartrend |
6502 Free Analysis |
|
|
6502 Important Levels Intraday
| RESISTANCE | 0.16 |
| RESISTANCE | 0.15 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.13 |
| SUPPORT | 0.11 |
| SUPPORT | 0.10 |
| SUPPORT | 0.09 |
| SUPPORT | 0.08 |
6502 Forecast May 2024
| 4th UP Forecast | 2.36 |
| 3rd UP Forecast | 1.64 |
| 2nd UP Forecast | 1.2 |
| 1st UP Forecast | 0.75 |
| 1st DOWN Forecast | -0.51 |
| 2nd DOWN Forecast | -0.96 |
| 3rd DOWN Forecast | -1.4 |
| 4th DOWN Forecast | -2.12 |
6502 Weekly Forecast
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.49 |
| 1st UP Forecast | 0.34 |
| 1st DOWN Forecast | -0.10 |
| 2nd DOWN Forecast | -0.25 |
| 3rd DOWN Forecast | -0.40 |
| 4th DOWN Forecast | -0.65 |
6502 Forecast2024
| 4th UP Forecast | 5.88 |
| 3rd UP Forecast | 4.03 |
| 2nd UP Forecast | 2.89 |
| 1st UP Forecast | 1.75 |
| 1st DOWN Forecast | -1.51 |
| 2nd DOWN Forecast | -2.65 |
| 3rd DOWN Forecast | -3.79 |
| 4th DOWN Forecast | -5.64 |
OpGen Inc ( F Germany Symbol : 6502 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
6502 Business Profile
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is based in Rockville, Maryland. Address: 9717 Key West Avenue, Rockville, MD, United States, 20850
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service